Premarket Decliner
LPCN Lipocine9.25+1.26+15.8%
Premarket:1.89-7.36 (-79.6%)
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
PRNewswireThu, 2-Apr 8:00 AM
LPCN Lipocine0.93-0.06 (-5.8%)
LPCN Lipocine1.86+0.01 (+0.5%)
LPCN Lipocine1.44+0.03 (+2.1%)
LPCN Lipocine1.45-0.02 (-1.4%)